Cargando…
A Patient Self-Made Point-of-Care Fecal Test Improves Diagnostic Accuracy Compared with Fecal Calprotectin Alone in Inflammatory Bowel Disease Patients
Background: Monitoring inflammatory bowel disease patients may be challenging. Fecal calprotectin is one of the most performed tests. Other fecal biomarkers are less used in clinical practice. Rapid fecal tests that could be performed by patients may be a useful strategy to closely monitor disease a...
Autores principales: | Hijos-Mallada, Gonzalo, Velamazán, Raul, Marti, Raúl, Chueca, Eduardo, Arechavaleta, Samantha, Lué, Alberto, Gomollón, Fernando, Lanas, Angel, Sostres, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700108/ https://www.ncbi.nlm.nih.gov/pubmed/34943560 http://dx.doi.org/10.3390/diagnostics11122323 |
Ejemplares similares
-
The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2021) -
A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal Cancer
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2023) -
Reducing the Cut-Off Value of the Fecal Immunochemical Test for Symptomatic Patients Does Not Improve Diagnostic Performance
por: Navarro, Mercedes, et al.
Publicado: (2020) -
The combination of quantitative faecal occult blood test and faecal calprotectin is a cost-effective strategy to avoid colonoscopies in symptomatic patients without relevant pathology
por: Lué, Alberto, et al.
Publicado: (2020) -
Fecal occult blood and calprotectin testing to prioritize primary care patients for colonoscopy referral: The advantage study
por: Lanas, Ángel, et al.
Publicado: (2023)